# GastricPath AI — Master Implementation Status Tracker

**Document ID:** `GP-STATUS-2026-V1`  
**Current Phase:** Phase 3.3.1 Complete (Scientific Audit & Baseline Finalization Complete; 68/68 Tests Passing) — Awaiting User Authorization  
**Last Updated:** November 2026  

---

## Status Legend

| Status | Meaning |
|:---|:---|
| **Not started** | Planned feature not yet initiated. |
| **In progress** | Active development underway. |
| **Implemented** | Code written and operational. |
| **Tested** | Verified with automated tests and empirical validation. |
| **Blocked by data** | Requires external datasets or clinical linkage not present in repository. |
| **Blocked by hardware** | Requires specialized compute (e.g. CUDA GPU with large VRAM) currently unavailable. |
| **Experimental** | Proof-of-concept / exploratory feature. |

---

## Feature Matrix by Phase

### Phase 0: Repository Audit & Baseline Preservation
| Module / Feature | Description | Status | Notes |
|:---|:---|:---:|:---|
| Existing Repository Audit | Complete inspection of backend, frontend, ML, data, and DB | **Tested** | Documented in `docs/REPOSITORY_AUDIT.md` |
| Baseline Preservation | Git repository initialized; clean backup on branch `gastricpath-ai-evolution` | **Tested** | Commit `117d81d` verified |
| Baseline Application Verification | FastAPI server running on `127.0.0.1:8000` with 200 OK | **Tested** | Verified via live HTTP health & dashboard probes |
| Dataset Extraction & Verification | Verify 31,096 images placed across all 8 classes | **Tested** | 3,887 images per class verified in `data/raw/` |

---

### Phase 1: Research Infrastructure & Reproducibility
| Module / Feature | Description | Status | Notes |
|:---|:---|:---:|:---|
| Centralized Research Configuration | YAML/Pydantic V2 unified configs for seeds, paths, device | **Tested** | `research/config.py` & `base_research.yaml` verified by tests |
| Reproducibility & Provenance Engine | Multi-library seed control, telemetry capture & non-determinism disclosures | **Tested** | `research/reproducibility.py` verified by tests |
| Local Experiment Tracker | Local JSON/JSONL tracker with metric streaming & manifest logging | **Tested** | `research/tracking/experiment_tracker.py` verified by tests |
| Medical AI Model Registry | Model metadata schema, chunked SHA-256 verification & catalog | **Tested** | `research/registry/model_registry.py` verified; baseline registered |
| Automated Test Suite | Unit, regression, ML tensor and database tests (21 tests) | **Tested** | 21/21 passed in 26.33s; configured via `pytest.ini` |
| Inference Latency Optimization | Lazy prototype dataset loading reducing cold-start latency | **Tested** | Import time reduced from 51.6s to 0.46s |

---

### Phase 2: Dataset Audit, Manifests & Splitting
| Module / Feature | Description | Status | Notes |
|:---|:---|:---:|:---|
| Image Integrity & Corruption Scanner | Automated verification of image dimensions, channels, and readability | **Tested** | 31,096 images scanned: 0 corrupt, 100% 224x224, 100% RGBA (lossless RGB) |
| Exact Duplicate Detection (SHA-256) | Bitwise duplicate detection and cross-class contradiction audit | **Tested** | 29,910 unique hashes, 932 duplicate groups, 0 cross-class conflicts |
| Near-Duplicate & Leakage Detection | Perceptual hashing (dHash) & DSU clustering (Hamming <= 2) | **Tested** | 932 intra-class clusters, 0 cross-class clusters, multi-index candidate table |
| Canonical Master Manifest | Reproducible sorted dataset manifest with SHA-256 and dHash | **Tested** | `research/manifests/manifest_all.csv` (31,096 records) |
| Leak-Proof Group-Stratified Splits | 70% Train, 15% Val, 15% Test with zero cross-split duplicate leakage | **Tested** | 21,767 train / 4,664 val / 4,665 test; mutual exclusivity verified |
| Patient/Slide Linkage Audit | Documentation of unlinked GCHTID filenames | **Tested** | Verified: filenames do not encode patient IDs; image-level split disclosed |

---

### Phase 3 & 3.1: Classification Benchmark Suite & Scientific Verification Audit
| Module / Feature | Description | Status | Notes |
|:---|:---|:---:|:---|
| Existing CNN-BiLSTM-Attention Baseline | Full 4,665 test-image evaluation of original sequence checkpoint | **Tested** | 71.04% Acc [69.72, 72.32], 71.14% Macro-F1, 0.9593 AUROC, 0.0167 ECE |
| Standard ResNet50 Classifier Baseline | Standard 2D CNN pathology baseline (`research/benchmark/models.py`) | **Tested** | Initialized with random weights (`pretrained=False`); zero external downloads |
| EfficientNet / ConvNeXt Baseline | Lightweight convolutional baseline suited for CPU/edge inference | **Tested** | Implemented EfficientNet-B0 (4.0M params) with dynamic input transforms |
| Comprehensive Evaluation Metrics | Macro/weighted F1, Cohen's kappa, OvR AUROC, ECE, Brier score | **Tested** | Verified with synthetic edge cases; Wilson & bootstrap 95% CIs |
| Historical Discrepancy Investigation | Forensic analysis of 56.82% notebook vs. 71.04% verified accuracy | **Tested** | 56.82% traced to Keras Conv2D model; PyTorch sequence baseline achieved 71.04% |
| Scientific Disclaimer on Cancer Percentage | Explicit separation of class probabilities from true tumor area fraction | **Tested** | Integrated into benchmark summaries, reporting, and model registry |

---

### Phase 3.2: Checkpoint Training-Lineage & Duplicate-Aware Evaluation Audit
| Module / Feature | Description | Status | Notes |
|:---|:---|:---:|:---|
| Checkpoint Lineage Recovery | Exact provenance recovery of `gastric_rnn_classifier.pt` | **Tested** | 100% mapped: checkpoint matches Epoch 15 (val_acc: 64.86%) trained on `dataset_manifest.csv` |
| Train-Test Overlap Audit | Forensic mapping of Phase 3.1 test set (N=4,665) against historical training data | **Tested** | **CONTAMINATED**: 3,758 / 4,665 (80.56%) were historical training images; 465 (9.97%) val; 442 (9.47%) test |
| Memorization Gap Quantification | Measurement of accuracy divergence between training vs unseen images | **Tested** | 72.99% on historical train vs. 65.84% on genuinely unseen test images ($\Delta = 7.15\%$) |
| Test Duplicate Cohort Analysis | SHA-256 and dHash duplicate structure audit within 4,665 test files | **Tested** | 4,496 unique SHA-256 hashes, 169 duplicate files, 136 groups; 0 label conflicts; 100% prediction consistency |
| Duplicate-Aware Metric Estimation | File-weighted vs exact-unique metrics comparison | **Tested** | File-weighted Acc 71.04% vs Unique Acc 70.93% ($\Delta = -0.11\%$); duplicates had minimal metric impact |
| Cluster-Bootstrap Uncertainty ($B=1000$) | Indivisible cluster resampling across 4,496 clusters | **Tested** | Accuracy 95% Cluster CI: [0.6969, 0.7245]; Macro-F1 95% Cluster CI: [0.6973, 0.7250] |
| Benchmark Integrity Classification | Definitive classification of baseline benchmark integrity | **Tested** | Classified as **CONTAMINATED**; machine-readable audit artifacts stored in `research/audits/phase3_2/` |

---

### Phase 3.3 & 3.3.1: Historical Test Evaluation, Final Baseline Certification & Statistical Audit
| Module / Feature | Description | Status | Notes |
|:---|:---|:---:|:---|
| Full Historical Test Set Evaluation | Deterministic evaluation of original checkpoint across all 3,110 historical test images | **Tested** | 65.92% Acc [0.6423, 0.6756], 66.11% Macro-F1, 0.9392 AUROC, 0.0357 ECE |
| Cross-Split Duplicate Audit | Audit SHA-256 & dHash leakage across historical Train/Val/Test | **Tested** | 174 test images had exact match in Train; 34 in Val; 0 label conflicts; 93.83% strictly unexposed |
| Duplicate Exposure Discrepancy | Compare model performance on training duplicates vs clean test samples | **Tested** | 70.69% on train duplicates vs. 65.63% unexposed ($\Delta = +5.06\%$ exposure difference) |
| Deduplicated & Sensitivity Benchmarks | Evaluate exact-unique (N=3,090) and strictly unexposed (N=2,918) cohorts | **Tested** | Unique Acc: 65.95%; Strictly Unexposed Acc: 65.66% [0.6392, 0.6736] |
| Cluster-Bootstrap Uncertainty ($B=1000$) | Resample 3,090 indivisible clusters for empirical confidence intervals | **Tested** | Cluster 95% CI: Accuracy [0.6421, 0.6759], Macro-F1 [0.6444, 0.6775]; 100% reproducible |
| Independent Statistical Audit & Finalization | Recompute metrics, reconcile cohort arithmetic, and correct overconfident language | **Tested** | Documented in `docs/PHASE3_3_1_FINAL_BASELINE_AND_STATISTICAL_AUDIT_REPORT.md` (68 tests passing) |

---

### Phase 4: Pathology Foundation Models
| Module / Feature | Description | Status | Notes |
|:---|:---|:---:|:---|
| Foundation Model Adapter Interface | Modular plug-in architecture for pathology encoders | **Not started** | Planned |
| DINOv2 / Phikon Feature Extractor | Extract 768-dim embeddings from histopathology patches | **Not started** | CPU-compatible feature extraction |
| Embedding Cache & Storage | Parquet / NumPy embedding matrix storage on disk | **Not started** | Prevents repeated model forward passes |
| FAISS Similarity Retrieval Engine | Top-K similar patch retrieval for morphologically identical lesions | **Not started** | Planned |
| Heavy Foundation Models (UNI, UNI2, Gigapath) | Large pathology vision transformers (>1B parameters) | **Blocked by hardware** | Requires GPU VRAM (>12GB) and gated model weights |

---

### Phase 5: Explainability & Uncertainty
| Module / Feature | Description | Status | Notes |
|:---|:---|:---:|:---|
| Grad-CAM Visual Attribution | Gradient-weighted class activation mapping on CNN feature maps | **Not started** | Planned for CNN & RNN encoders |
| Spatial Attention Map Visualization | Extract and visualize the 16-patch additive attention weights | **Not started** | Native to `GastricCancerRNN` |
| Expected Calibration Error (ECE) & Reliability Plots | Measure prediction calibration across confidence bins | **Not started** | Planned |
| Temperature Scaling Post-Processing | Calibrate model output logits on validation set | **Not started** | Planned |
| Uncertainty Estimation & Abstention | Flag out-of-distribution or ambiguous patches for pathologist review | **Not started** | Replaces forced hard decisions |

---

### Phase 6: Tissue Segmentation
| Module / Feature | Description | Status | Notes |
|:---|:---|:---:|:---|
| Patch-Level Mask Prediction (U-Net) | Pixel-level semantic delineation of epithelium, stroma, and necrosis | **Blocked by data** | GCHTID lacks pixel-level ground truth masks |
| Synthetic/Pseudo-Mask Tissue Delineation | Color deconvolution & threshold-based tissue area segmentation | **Experimental** | Feasible for tissue boundary extraction |
| Quantitative Tissue Composition | Exact square-micrometer and percentage area of tissue compartments | **Blocked by data** | Requires validated segmentation masks |

---

### Phase 7: Nuclei Detection & Cellular Morphology
| Module / Feature | Description | Status | Notes |
|:---|:---|:---:|:---|
| H&E Nuclei Detection Engine | Detect individual cell nuclei centroids and boundaries | **Experimental** | Lightweight StarDist / watershed engine |
| Morphological Feature Extractor | Calculate nuclear area, circularity, perimeter, and aspect ratio | **Not started** | Derived from detected nuclei |
| Tumor-Infiltrating Lymphocyte (TIL) Density | Quantify lymphocytes in stroma vs tumor parenchyma | **Not started** | Depends on nuclei detection |
| Heavy HoVer-Net Full Multi-Class Instance Segmentation | Complete pan-cancer multi-tissue cell classification | **Blocked by hardware** | High compute overhead on CPU |

---

### Phase 8: Spatial Graph Learning & GNN Engine
| Module / Feature | Description | Status | Notes |
|:---|:---|:---:|:---|
| Spatial Cell Graph Construction | Build graphs where nodes = nuclei, edges = Delaunay / k-NN spatial proximity | **Not started** | Planned |
| Graph Neural Network Baseline (GCN / GAT) | Predict tissue patch phenotype from cellular graph topology | **Not started** | PyTorch Geometric CPU fallback |
| Spatial Microenvironment Profiling | Quantify tumor-stroma cellular clustering and cellular dispersion | **Not started** | Planned |

---

### Phase 9: Whole-Slide Image (WSI) Engine & Multiple Instance Learning
| Module / Feature | Description | Status | Notes |
|:---|:---|:---:|:---|
| OpenSlide WSI Reader & Metadata Parser | Multi-resolution pyramid reader for `.svs`, `.ndpi`, `.mrxs` | **Not started** | Software ready |
| Digital Whole Slide Images | Gigapixel surgical resection gastric cancer slides | **Blocked by data** | Zero WSIs in repo (only 224x224 patches) |
| Multiple Instance Learning (Attention MIL / CLAM) | Aggregate slide bags into slide-level diagnosis | **Blocked by data** | Requires slide-level ground-truth labels |
| Deep-Zoom Heatmap Viewer (OpenSeadragon) | Interactive pan-and-zoom WSI attention overlay viewer | **Not started** | UI architecture planned |

---

### Phase 10: Multimodal Clinical Research
| Module / Feature | Description | Status | Notes |
|:---|:---|:---:|:---|
| Clinical Cohort Analyzer | Exploratory analysis of 300 HMU patients (TNM, HER2, Lauren) | **Implemented** | Active on dashboard |
| Biomarker Prediction Browser | Exploration of 3,711 miRNA target predictions | **Implemented** | Active on dashboard |
| Multimodal Image-Clinical Deep Fusion | Combined representation of patient slide and clinical variables | **Blocked by data** | GCHTID patches lack patient IDs to link with HMU-GC-Clinical.csv |
| Patient Survival Modeling (Cox-PH / DeepSurv) | Time-to-event survival analysis | **Blocked by data** | Clinical CSV lacks survival time & vital status (death/recurrence) |

---

### Phase 11: Research Workbench UI
| Module / Feature | Description | Status | Notes |
|:---|:---|:---:|:---|
| Existing Live Inference UI | Preserve current 8-class upload, probabilities, and history | **Implemented** | Working on `127.0.0.1:8000` |
| Research Navigation Shell | Multi-tab research workbench layout | **Not started** | Planned |
| Model Comparison & Leaderboard Tab | Compare metrics, confusion matrices, and ROC curves | **Not started** | Planned |
| Spatial & Explainability Inspector Tab | View Grad-CAM overlays and attention distributions | **Not started** | Planned |
| Dataset Provenance & Split Explorer Tab | Search and inspect dataset patches with label provenance | **Not started** | Planned |

---

### Phase 12: Testing, Deployment & Research Release
| Module / Feature | Description | Status | Notes |
|:---|:---|:---:|:---|
| Full Automated Test Suite (pytest) | 100% test coverage across core API and ML pipelines | **Not started** | Planned |
| Model Cards & Scientific Documentation | Standardized model cards reporting accuracy, limits, and biases | **Not started** | Planned |
| Docker Containerization | Containerized deployment environment | **Not started** | Planned |
| Final Research Summary Report | Comprehensive benchmark report ready for publication review | **Not started** | Planned |

---

## Next Immediate Action

**Phase 3.3.1 — Scientific Audit Corrections & Baseline Finalization Complete:**  
The baseline GastricCancerRNN checkpoint evaluation has been independently verified across all metrics (Accuracy: **65.92%**, Strictly Duplicate-Unexposed Accuracy: **65.66%**). All duplicate-exposure arithmetic ($+0.26\%$ empirical shift vs. $+0.28\%$ marginal contribution) has been reconciled. The cluster-bootstrap interval ($[0.6421, 0.6759]$) is verified as 100% reproducible with seed 42. All overconfident terminology has been corrected to neutral scientific standards. 68/68 automated tests pass.

**Awaiting User Review & Authorization for Phase 4:**  
Awaiting explicit authorization to initiate **Phase 4: Pathology Foundation Models (DINOv2, Phikon embeddings, feature caching, and FAISS similarity retrieval)**.

